NCT00359281View on ClinicalTrials.gov

Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Healthy
Interventions
DRUG

atorvastatin

Atrovastatin 20 mg and AEGR-733 10 mg or 60 mg

DRUG

simvastatin

Simvastatin 20 mg and AEGR-733 10 mg or 60 mg

DRUG

ezetimibe

Ezetimibe 10 mg and AEGR-733 10 mg

DRUG

fenofibrate

Micronized Fenofibrate 145 mg and AEGR-733 10 mg

DRUG

dextromethorphan

Dextromethorphan 30 mg and AEGR-733 10 mg

DRUG

Extended Release Niacin

1000 mg ER niacin and AEGR-733 10 mg

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors
All Listed Sponsors
lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY